Clinical Features of Refractory Pouchitis with Penetrating Lesions and the Efficacy of Infliximab Treatment for Patients with Ulcerative Colitis after Restorative Proctocolectomy

Background: Chronic pouchitis with penetrating anal lesions often leads to pouch failure after restorative proctocolectomy. The aim of this study was to analyze those predictors and to evaluate the effects of infliximab (IFX). Methods: We reviewed patients' backgrounds and performed a prospective trial of IFX treatment. Possible pre-operative factors were analyzed. Efficacy was assessed by comparing the pouchitis disease activity index (PDAI) and peri-anal DAI. Long-term efficacy was assessed via the rate of pouch failure. Results: A total of 41 patients with refractory pouchitis were included. Although the patients with penetrating lesions were younger than those without, neither predictive pre-operative factors nor a correlation of C-related protein levels were observed. A total of 10 patients with penetrating lesions were enrolled for IFX treatment. Although the PDAI and peri-anal DAI decreased significantly (p = 0.04 and p = 0.02, respectively), the primary non-responders during the induction of IFX were 3 patients with obvious abscesses. The 1-year cumulative pouch failure rate was 0% in patients without abscesses and 50% in patients with abscesses under IFX maintenance. Conclusions: IFX treatment for refractory pouchitis with penetrating complications appears to be effective. However, once penetrating lesions develop to abscesses, these lesions are difficult to heal.

[1]  H. Ikeuchi,et al.  Clinical features and management of pouchitis in Japanese ulcerative colitis patients , 2013, Surgery Today.

[2]  Liam A. Haveran,et al.  Infliximab and/or Azathioprine in the Treatment of Crohn's Disease-Like Complications After IPAA , 2011, Diseases of the colon and rectum.

[3]  Elena A. Manilich,et al.  Quantification of Risk for Pouch Failure After Ileal Pouch Anal Anastomosis Surgery , 2003, Annals of surgery.

[4]  H. Järvinen,et al.  Cumulative Failure Rate of Ileal Pouch-Anal Anastomosis and Quality of Life After Failure , 2002, Diseases of the colon and rectum.

[5]  P. gordon,et al.  Ileoanal anastomosis with reservoirs: complications and long-term results. , 1999, Canadian journal of surgery. Journal canadien de chirurgie.

[6]  R. Farouk,et al.  J ileal pouch–anal anastomosis for chronic ulcerative colitis: complications and long‐term outcome in 1310 patients , 1998, The British journal of surgery.

[7]  Z. Cohen,et al.  Risk factors for pelvic pouch failure , 1997, Diseases of the colon and rectum.

[8]  M. Keighley,et al.  Causes of failure and life expectancy of the ileoanal pouch , 1997, International Journal of Colorectal Disease.

[9]  R. Löfberg,et al.  Pouchitis following pelvic pouch operation for ulcerative colitis , 1996, Diseases of the colon and rectum.

[10]  M. Molinari,et al.  Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. , 1996, Archives of surgery.

[11]  N. LaRusso,et al.  Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. , 1996, Gut.

[12]  J. Church,et al.  IIeal Pouch‐Anal Anastomoses Complications and Function in 1005 Patients , 1995, Annals of surgery.

[13]  Irvine Ej.  Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. , 1995 .

[14]  E. Irvine.  Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. , 1995, Journal of clinical gastroenterology.

[15]  K. Batts,et al.  Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. , 1994, Mayo Clinic proceedings.

[16]  R. Beart,et al.  Ileal pouch-anal anastomosis. Reoperation for pouch-related complications. , 1990, Annals of surgery.